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Poor sleep and obesity are both extraordinarily common in the US adolescent population
and often occur simultaneously. This review explores the links between obesity and sleep,
outlining what is known about the relationships between sleep characteristics, obesity,
and cardiometabolic risk factors in youth. Sleep duration is less than optimal in teens, and
decreases as age increases. This is detrimental to overall well-being and is associated
with obesity in children, adolescents, and young adults. Accordingly, inadequate sleep
duration is associated with poor diet quality, decreased insulin sensitivity, hyperglycemia,
and prevalent cardiometabolic risk factors. Evidence suggests that poor sleep quality
and altered circadian timing characterized by a preferred later sleep onset, known as
“adolescent chronotype,” contributes to shortened sleep duration. Obstructive sleep
apnea (OSA) occurs more frequently among youth with obesity, and is associated with
autonomic nervous system activity promoting higher blood pressure, increased markers
of cardiovascular disease risk, and insulin resistance. While there is a clear association
between OSA and type 2 diabetes in adults, whether or not this association is prevalent
in youth is unclear at this time. Interventions to improve both sleep duration and quality,
and obesity in adolescents are scarce and more evidence is needed to determine if such
interventions can improve obesity-related health outcomes.
Keywords: obesity, poor sleep, obstructive sleep apnea, sleep duration, sleep quality, diet quality, cardiometabolic
risk, insulin sensitivity
INTRODUCTION
Data from the National Health and Nutrition Examination Survey (NHANES) shows the
prevalence of obesity, defined as having a body mass index (BMI) at or above the 95th percentile
for age and sex, in 2–19 year old youth was 16.8% in 2007–2008 and increased to 18.5% (nearly
1 in 5) in 2015–2016 (1). In addition, since 2013–2014, there has been a significant increase in
obesity among youth ages 2–5 years, with an increase in prevalence from 9.3 to 13.7% in 2015–
2016 (2). Thus, the burden of childhood obesity in the US continues to increase and as more youth
are affected, co-morbid conditions are becoming more common (1).
Short sleep duration and poor sleep quality are also common in the pediatric population,
especially in teens (3). Whether or not these two increasingly prevalent pediatric problems are
physiologically linked is a topic of investigation and associations between sleep characteristics
and obesity are beginning to be better understood. This review explores the links between obesity
and sleep, outlining what is known about the relationships between sleep characteristics, obesity,
and cardiometabolic risk factors in youth with a particular focus on sleep duration and obesity, and
obstructive sleep apnea (OSA) and its metabolic consequences.
Gohil and Hannon Poor Sleep and Obesity
OPTIMAL SLEEP
It is clear that the majority of youth are sleeping less than
is recommended for optimal health. In 2015 the National
Sleep Foundation released recommendations for optimal sleep
durations for healthy individuals (4). It is recommended that
school-aged children, ages 6–13 years, should target 9–11 h of
sleep per night, while adolescents, ages 14–17 years, should target
8–10 h of sleep per night. However, according to a 2006 survey
conducted by the National Sleep Foundation, actual self-reported
sleep times were significantly less than 9 h in all adolescent age
groups and progressively declined from early to late adolescence
(5). Adolescents ages 11–12 years reported a mean sleep duration
of 8.4 h, while adolescents ages 17–18 years reported just
6.9 h of sleep per night. This shortened sleep duration was
largely due to later bedtimes and the adolescents were self-
aware of their deficient sleep. This is particularly important
because adolescents are not meeting their physiological needs for
restorative sleep. Adolescent “sleep need,” defined as the amount
of sleep recorded when adolescents are given the opportunity
to sleep for 10 h, is approximately 9 h and remains unchanged
throughout adolescence (5).
SLEEP DURATION AND OBESITY
Sleep duration has been associated with obesogenic behaviors
and obesity prevalence in both adult and youth populations. A
study of 240 toddlers from low-income families demonstrated
that decreased mean sleep duration from 9.2 to 8.5 h was
significantly associated with obesity (6). Moderate-to-vigorous
physical activity, measured with an Actical accelerometer, was
positively related to sleep duration. While sleep characteristics
such as co-sleeping, room sharing, later sleep onset time,
increased sleep latency, and night awakenings did not correlate
with obesity, they were associated with decreased sleep duration
and obesogenic behaviors including less physical activity and
poorer diet quality.
The precise mechanisms linking rapid eye movement (REM)
sleep and obesity are incompletely understood, but may include
decreased sleeping metabolic rate, and endocrine changes
associated with decreased leptin and increased ghrelin levels
promoting increased food consumption (7). Sleep deprivation
is associated with decreased insulin sensitivity via alterations of
the hormonal milieu including cortisol, ghrelin, leptin, growth
hormone, and glucose tolerance (8, 9). These hormonal changes
cause alterations in energy regulation, unhealthy food choices,
increased food consumption, decreased physical activity, and
perhaps a reduction in non-exercise activity thermogenesis.
Decreased REM sleep is observed in individuals with short
sleep duration, and has been a proposed mechanism for the
link between short sleep duration and increased weight status.
A study by Liu et al. involving 335 youth examined sleep stages
using polysomnography and found significant differences in
overweight children compared to normal-weight children, as
they slept less, had reduced sleep efficiency, decreased REM sleep
time, activity and density, and longer latency to the first REM
episode (7). After adjustment for demographics, pubertal status,
and confounding medical conditions, 1 h less of REM sleep was
associated with an approximately 2-fold increased odds of being
overweight, and 1 h less of REM sleep was associated with an
approximately 3-fold increased odds of being overweight.
Leptin and ghrelin are key hormones involved in appetite
regulation (10). In their review article, Van Cauter et al. discussed
neuroendocrine control of food intake (11). In sleep-restricted
as opposed to well-rested individuals, leptin levels are decreased
while ghrelin levels are increased resulting in subjective hunger.
The amount of sleep restriction varied among the reviewed
studies. Much less is known about leptin and ghrelin secretion
and operation in children. Recent studies have shown conflicting
results. While one study showed short sleep duration was
associated with lower leptin levels, the other revealed short sleep
duration was associated with higher leptin levels (12). Table 1
summarizes some proposed mechanisms for poor sleep and
obesity and some obesogenic behaviors seen in those with poor
sleep.
The associations between sleep duration and obesity are
thought to be mediated, at least in part, by diet quality.
Less sleep is consistently linked with unhealthy dietary habits
including larger portion sizes, increased perceived hunger,
higher calorie food choices, and increased food and sugar-
sweetened beverage intake (13, 14). Cespedes et al. examined
1,046 parental reports of sleep and diet in children from
infancy to mid-childhood (15). Sleep was measured using a
calculated sleep score based on parental reported sleep duration.
Diet was measured using the Youth Healthy Eating Index
(YHEI). Chronic sleep insufficiency was associated with lower
YHEI score. Looking independently at each factor, children
with less sleep and a less healthy diet had a higher BMI
z-score. It is not known whether or not these were causal
associations.
A systematic review and meta-analysis of 17 observational,
cohort, cross-sectional, and case-control studies from 9 countries
found convincing evidence of the link between shorter sleep
duration and childhood obesity (9). Sleep durations of less than
9 h (children 10 years of age or older), less than 10 h (children
between 5 and 10 years of age), and less than 11 h (children less
than 5 years of age) were associated with a 58% increased risk of
being overweight or obese. Each hour increase in sleep duration
was associated with a 9% reduced risk of being overweight or
obese. Interestingly, the decreased sleep duration (defined by
TABLE 1 | Proposed mechanisms and obesogenic behaviors in poor sleep and
obesity.
Proposed mechanisms Obesogenic behaviors
• Evening Chronotype
◦ With early wake time
◦ Social jetlag
• Bedtime Shift
• Hormonal Alterations
◦ Leptin
◦ Ghrelin
• Unhealthy Food Choice
◦ Sugar-sweetened beverages
◦ Fast food
◦ High calorie snacks
◦ Excessive portion sizes
• Increased food consumption
• Increased perceived hunger
• Food preoccupation
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each studies’ own criteria) and obesity association appeared to
be stronger for boys than girls, with an odds ratio of 2.50
vs. 1.24 respectively (9), although the reason for this gender
variance is not known and data from studies are conflicting (16–
18). Cappuccio et al. published a meta-analysis reviewing the
association between sleep duration and obesity in both youth
and adults (19). Results in children correlated with previous
findings (9), with an increased pooled odds of 1.89 for a shortened
sleep duration associated with obesity (19). This association
was also observed in adults from 12 countries and in various
age groups from adolescence through late-adulthood, showing
their results had a similar effect across populations and age
groups.
Modifiable factors presumed to cause decreased sleep duration
include evening exposure to electronic media, early school start
times, academic workload, and caffeine consumption (3, 20). A
systematic review of 33 studies to investigate the relationship
between short sleep duration and potential mechanisms such
as dietary habits, physical activity or lack thereof, screen time,
and hormonal effects including, alterations in leptin and ghrelin
levels, found evidence for associations of sedentary behavior,
unhealthy dietary patterns, and insulin resistance with shorter
sleep duration (8). Insulin resistance was assessed using one
randomized controlled trial, one prospective cohort study, and
one cross-sectional study, two with a negative association and
one with a U-shaped association between sleep duration and
HOMA-IR (homeostatic model assessment of insulin resistance).
Conclusions for other mechanisms of physical activity, screen
time, changes in leptin and ghrelin levels were indeterminate,
attributed to lack of current evidence and need for more rigorous
research.
SLEEP QUALITY AND OBESITY
Other indicators of sleep quality beside sleep duration have also
been implicated as risk factors for obesity, although data are
sparse. The National Sleep Foundation identified indicators of
sleep quality for all age groups as: sleep onset latency, number
of awakenings lasting less than 5min, wake time after sleep
onset, and sleep efficiency (ratio of total sleep time to time in
bed) (21). Part of a cross sectional study by Quick et al. of
1,252 college students across nine U.S. universities evaluated
sleep quality by self-report using the Pittsburgh Sleep Quality
Index and weight status using two categories, normal weight
(BMI less than 25) and overweight or obese (BMI 25 or greater)
(22). Poorer sleep quality was significantly associated with being
overweight or obese with an odds ratio of 1.07 (95% CI 1.01–
1.13).
Fatima et al. published the first systematic review and meta-
analysis looking at associations between sleep quality using
the Pittsburgh Sleep Quality Index and overweight and obesity
in youth (23). Poorer self-reported sleep quality, defined as
higher sleep onset latency, more sleep disturbances, recurrent
awakenings, and lower sleep efficiency, was associated with a
higher odds of being overweight or obese (odds ratio of 1.46, 95%
CI of 1.24–1.72), independent of sleep duration.
However, some studies have not found an association between
sleep quality measures aside from sleep duration and weight
status in younger children (24–26). When sleep quality measures
of sleep latency, wake after sleep onset, sleep duration, and sleep
efficiency were collected using a parental-reported sleep diary
and objectively using wrist actigraphy, no association was found
between sleep quality and body mass index, body fat percentage,
or waist circumference (26). Of note, there was a low prevalence
of overweight and obese subjects in this study, with only 7%
having a BMI in this range.
SLEEP CHRONOTYPE AND OBESITY
Adolescent preferred sleep patterns lead to decreased sleep times,
both because their biologic circadian rhythm shifts toward later
sleep and wake times resulting in a “late chronotype” and because
of competing interests to complete schoolwork and socialize
during evening and nighttime hours (3). Chronotype is the
sleep timing of an individual or that individual’s propensity to
sleep during a particular time. Early adolescence and puberty
are biologically linked to later bed time and wake time
preferences, known as an evening-type circadian rhythm or
evening chronotype. Pubertal adolescents and young adults have
a slower escalation in “drive-to-sleep” or lower sleep pressure,
compared with their prepubertal counterparts. As sleep onset is
delayed by both biological and societal influences and wake times
tend to be fixed, sleep deprivation accumulates.
“Bedtime shift” describes later bed times on weekends
compared to weekdays and may also affect the circadian rhythm
as the circadian clock cannot adapt quickly to shifts in sleep onset.
Independent of sleep duration, greater bedtime shift is linked to
obesity severity (14). Circadian rhythm disorder or delayed sleep-
phase syndrome is associated with daytime sleepiness and can
lead to napping after school, ending ultimately with difficulty
sleeping at night. In 186 adolescents, ages 12–17 years, sleep
quality assessed using the self-reported Insomnia Severity Index,
was not related to a higher BMI z-score (14). However, there
was a significant association between a higher BMI z-score and
a later weekend bedtime, and a greater bedtime shift. Ivers-
Landis et al. evaluated self and parent-reported dietary, sleep
duration, and sleep regularity parameters (bedtime shift, wake-
time shift, and sleep duration shift) among 315 overweight
and obese adolescents (27). Late bedtime shift and wake-time
shift were associated with increased sugar-sweetened beverage
consumption and food preoccupation.
Both biological influence and social influences that encourage
later sleep times and decreased sleep duration are associated
with obesity. Social jetlag describes the alterations in one’s
chronotype due to social obligations such as school, work, or
other social events. Roenneberg et al. assessed social jetlag and
obesity in a database of 64,110 primarily central European
subjects, ages 16–65 years, who had completed the Munich
ChronoType Questionnaire (28). Social jetlag, defined as the
difference between mid-sleep point on free days vs. work days,
significantly increased the odds of being overweight by 3.3 (95%
CI 2.512–4.334). The association between a late chronotype
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and BMI was studied in 511 young adolescents, ages 11–13
years, in the United Kingdom by Arora and Taheri in a cross-
sectional study (29). A definitely evening chronotype, identified
by the lowest score category on the self-reported Morningness
Eveningness Questionnaire, represented 15.3% of the sample size
and was positively associated with BMI z-score (p < 0.01).
Hulsegge et al. compared diet quality and quantity between
7,173 adult day workers and 683 adult shift workers using cross-
sectional general population data from the European Prospective
Investigation into Cancer and Nutrition-Netherlands cohort
(30). Dietary intake was assessed using a food frequency
questionnaire and dietary quality was assessed using the
Mediterranean Diet Score and WHO-based Healthy Diet
Indicator. Although shift workers had a similar diet quality to
day workers, their energy intake was higher by 56 kcal/day (95%
CI of 10–101). Shift workers with five or more night shifts per
month had the highest energy intake, taking in an additional
103 kcal/day (95% CI of 29–176) than day workers consumed.
These results suggest high energy intake may contribute to the
metabolic disturbances (30), such as increased body weight,
elevated systolic blood pressures, dysglycemia, type 2 diabetes,
dyslipidemia, and cardiovascular disease, which have been linked
with shift work (31).
SLEEP, GLUCOSE METABOLISM, AND
CARDIOMETABOLIC RISK
Current evidence indicates sleep disturbances contribute
to alternations in glucose metabolism and increased
cardiometabolic risk (32–34). Similar to adults, poor self-
reported sleep quality in youth has been associated with
components of the metabolic syndrome, including dyslipidemia,
higher blood pressure, and markers of insulin resistance (35–39).
Alterations in leptin, ghrelin, and cortisol levels and increased
sympathetic nervous system activity are thought to contribute to
an atherogenic lipid profile (40). Qian et al. proposed that sleep
fragmentation alters lipid metabolism via its effect on elevated
cortisol levels, increased systemic inflammation, increased
food intake, and obesity (41). Increased sympathetic nervous
system activity secondary to insufficient sleep contributes to
hypertension (38). Moreover, deficient deeper stages of sleep
(REM and slow-wave sleep) are associated with an elevated
morning blood pressure in obese adolescents, independent of
weight status (36). If poor sleep is contributing to elevated
blood pressures and metabolic syndrome in youth, interventions
should be pursued, as the cumulative effects of these risk factors
in obese youth are significant.
In 2016, the first study was published that investigated the
association between sleep deprivation and insulin sensitivity
performed via hyperglycemic clamp in 81 adolescents (32). Those
with sleep deprivation, defined as less than 8 h of sleep per night,
had a lower clamp-derived insulin sensitivity index, compared to
those with sufficient sleep, defined as 8 h or more.
Other pediatric studies indicate obese children and
adolescents who report less than 9 h of sleep per night have
higher fasting insulin and HOMA-IR levels, and lower
high-density lipoprotein cholesterol (HDL-C) levels (42).
Interestingly, a U-shaped distribution was observed, as those
with intermediate sleep durations, 9–10 h for 10–13 year olds
and 8–9 h for 14–15 year olds, had the lowest HOMA-IR, higher
HDL-C, and lower aspartate aminotransferase (AST). Those with
higher or lower sleep durations had higher HOMA-IR consistent
with greater insulin resistance. This U-shaped distribution has
been demonstrated for sleep duration and hemoglobin A1c
(HbA1c) and glucose levels during an oral glucose tolerance test
(OGTT) as well (33, 43).
OBSTRUCTIVE SLEEP APNEA IN OBESE
ADULTS WITH TYPE 2 DIABETES
A strong association between type 2 diabetes and OSA is seen
in overweight and obese adults (44). The Sleep AHEAD (Action
for Health in Diabetes) Study is an ancillary study measuring
the prevalence of OSA in participants in the Look AHEAD
study, a 16-center prospective trial examining the effects of an
intensive lifestyle program in overweight and obese adults with
type 2 diabetes (44). The Sleep AHEAD study demonstrated
an alarmingly high prevalence of undiagnosed OSA in this
population at 86% and an elevated average apnea-hypopnea
index (AHI) of 20.5 events per hour. The only significant
predictor of OSA was a higher waist circumference, but subjects
with a higher BMI were more likely to have severe OSA (44).
A meta-analysis of prospective cohort studies to evaluate the
association between OSA severity and the risk for type 2 diabetes
was performed by Wang et al. and included 6 prospective studies
with almost 6,000 adult patients (45). Included studies used only
objective measurements for the diagnosis of OSA and found
moderate (AHI 15 to less than 30) and severe OSA (AHI 30 or
greater) was an independent risk factor for type 2 diabetes in
adults. Another meta-analysis of prospective and retrospective
cohort studies in adults to assess the association between OSA
and metabolic syndrome involved 10 studies with just over
2,000 patients (46). This meta-analysis revealed OSA was a
significant risk factor for components of themetabolic syndrome,
specifically higher systolic blood pressure, lower HDL, higher
LDL (low-density lipoprotein), and higher triglyceride levels.
Importantly, the Sleep AHEAD study focused on the effect
of weight loss on OSA (47). The two intervention groups
in Look AHEAD and Sleep AHEAD are Intensive Lifestyle
Intervention (ILI) and Diabetes Support and Education (DSE).
ILI gives participants specific and detailed recommendations for
portion control, daily caloric intake limits, and a physical activity
requirement. Whereas DSE provides education and support on
diet, physical activity, and social support, but without specific
behavioral strategies (47, 48). Studies looking at the effects of
weight loss on OSA in obese adults with type 2 diabetes are
promising for the ILI group, as this group lost significantly more
weight and had a significant decrease in the AHI after 1 year (48).
At 1 year, three times more participants in the ILI than the DSE
group had total OSA remission and severe OSA prevalence was
halved in the ILI group. This effect of improved AHI in the ILI
group was sustained even over the long-term period of 4 years
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despite a 50% regain in weight, suggesting the benefits of this
program are more than just weight loss alone (47).
Proposed mechanisms for an association between OSA and
dysglycemia are multifactorial. OSA can lead to activation of the
sympathetic nervous system, increased leptin and ghrelin levels
contributing to increased appetite and food intake, decreased
adiponectin level, oxidative stress, inflammation and obesity
which all ultimately contribute to insulin resistance (49, 50).
The relationship between OSA and type 2 diabetes may be
explained by the stage of sleep when apneas and hypopneas are
occurring, as these episodes are longer and have greater oxygen
desaturations during REM vs. non-REM sleep, subsequently
leading to greater sympathetic nervous system activity (51).
These alterations may have an effect on insulin release and
activity as an altered sympathetic/parasympathetic balance may
affect hormones involved in glucose regulation (52). In a cohort
of 115 adult subjects, only the REM AHI was associated with an
increased HbA1c (52).
OBESITY AND METABOLIC
CONSEQUENCES OF OSA IN YOUTH
In youth, the association between OSA and type 2 diabetes is
less clear (33). Previous studies have shown inconsistencies across
studies in youth, with small sample sizes and pubertal effects on
insulin sensitivity affecting measures. A recent systematic review
and meta-analysis of 10 studies by Patinkin et al. attempted to
clarify relationships between OSA and metabolic risk markers
in youth by focusing on studies with exclusively adolescent
participants (53). OSA in adolescence was associated with
dyslipidemia, hypertension, and insulin resistance as measured
by HOMA-IR, as in adults.
A few pediatric studies have evaluated OSA and glucose
homeostasis in obese youth (54–57) and have provided
preliminary evidence of an association between OSA and lower
insulin sensitivity with increased fasting plasma insulin and
glucose levels, independent of BMI (33). Despite similar degrees
of obesity, adolescents with moderate or severe OSA (AHI 5
or greater), as opposed to mild or no OSA, had significantly
higher HOMA-IR (p = 0.0497) and fasting insulin levels
(p = 0.037) (58). Redline et al. reported a cohort study in
which 70% of adolescents with sleep-disordered breathing (SDB)
were overweight and 59% of them met criteria for metabolic
syndrome, notably elevated blood pressure, LDL, and fasting
insulin levels, again independent of BMI (57). Only 16% of
overweight adolescents without SDB had metabolic syndrome
and after adjustment for age, race, sex, and prematurity,
adolescents with SDB had an increased odds of 6.49 (95% CI
2.52–16.70) for metabolic syndrome compared to overweight
adolescents without SDB.
A study from Beijing, involving 558 participants ages 14–
28 years, demonstrated that even youth with high-risk for OSA
measured by self-reported Berlin Questionnaire score had higher
cardiometabolic risk including dyslipidemia, higher glucose
levels during OGTT, elevated liver enzymes, non-alcoholic fatty
liver disease, metabolic syndrome, and worse echocardiographic
parameters, specifically higher interventricular septum thickness,
left ventricular end diastolic diameter, and left ventricular
posterior wall thickness (59).
However, there are also pediatric studies which have not
reported a link between OSA and increased markers of
metabolic risk. Erdim et al. did not find an association
between OSA measured with overnight polysomnography and
metabolic syndrome in 104 obese adolescents (60). AHI was
1 or greater in 47.2% of youth without metabolic syndrome
and in 49% of youth with metabolic syndrome. In an
attempt to focus on the association of metabolic syndrome
and OSA in obese adolescents by minimizing confounding
factors, they uniquely excluded patients with grade 3 or 4
adenoidal or tonsillar hypertrophy, a known common cause
of OSA. Narang et al. found that intermittent nocturnal
hypoxia, not OSA measured by AHI was associated with
a higher fasting insulin level, more insulin resistance as
measured by HOMA-IR, higher HbA1c, and increased AST
and ALT after correction for waist-to-height ratio (61). These
studies used different criteria for evaluating metabolic risk and
therefore, larger studies with uniform outcome measures are
needed.
A prospective, cross-sectional study by Hannon et al. of
57 obese adolescents with either normal glucose tolerance,
dysglycemia, or type 2 diabetes showed those with dysglycemia
or type 2 diabetes tended to have a higher AHI, but no linear
relationship between glycemia and AHI was established (62).
Another prospective, cross-sectional study by Shalitin et al.
compared 11 obese youth with type 2 diabetes compared to 30
obese youth without diabetes who were BMI-SDS matched in
order to evaluate the frequency and severity of OSA between
these groups (63). The age range of youth for both groups
was 6–21 years and mild OSA was defined as an AHI greater
than 1, while moderate to severe OSA was defined as an
AHI 5 or greater. There was no significant difference in the
frequency or severity of OSA between obese patients with type
2 diabetes and those with normoglycemia. The power of these
relatively small studies to detect a significant association has
been limited. Nevertheless, if there is an association between
OSA and poor glycemic outcomes and type 2 diabetes in
youth, this would be important for intervention and prevention
efforts in these obese youth. This calls for more support
for large pediatric studies to clearly delineate the association
between OSA and dysglycemia in obese youth. Table 2 includes
suggested areas in need of further research, especially in
youth.
TABLE 2 | Areas for future research in sleep and obesity in youth.
• Sleep and Dyslipidemia
• Mechanisms to Determine Causality between Sleep
and Obesity
• Chronotype and Obesity
• Obesity and risk for Type 2 Diabetes
• OSA and risk for Type 2 Diabetes
• Sleep Interventions to Improve Obesity and
Cardiometabolic Risk
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OSA AND TREATMENT EFFECT
A systematic review of outcomes of OSA treatment in obese
youth showed that obese children are significantly more likely
to have persistent OSA after adenotonsillectomy than normal-
weight youth and consistent with results in adults, either behavior
or surgical weight loss, significantly improves OSA in obese
youth (64). However, studies are few and laden with limitations,
demonstrating the need for more research into weight loss as a
treatment option. Positive airway pressure is also effective, but
adherence is a major challenge (64). A systematic review and
meta-analysis of six studies assessed the effects of continuous
positive airway pressure (CPAP) in adult patients with type
2 diabetes and OSA (65). Results showed improved insulin
sensitivity, but no decrease in BMI or HbA1c level with at least
3 months of CPAP. Another adult study summarizing three
randomized controlled trials with 149 total patients showed
that CPAP withdrawal in patients with optimal compliance
was associated with a return of OSA and clinically significant
increases in blood pressure (66). In the CPAP withdrawal group
compared to the CPAP continuation group, office systolic blood
pressure, home systolic blood pressure, office diastolic blood
pressure, and home diastolic blood pressure all significantly
increased. In adults, improved CPAP adherence that involves
more coverage of REM sleep, can improve HbA1c (51, 52).
SLEEP INTERVENTIONS AND HEALTH IN
YOUTH
Although the association between poor sleep and obesity is clear,
causation has yet to be determined. Preliminary studies in youth
show some evidence that improved sleep may improve obesity
risk (67). In fact, interventions such as earlier bedtimes, later
wake times, and other healthy sleep behaviors could be low-cost
(9). A pilot study using a sleep hygiene program involving 33
adolescents showed improvement in self-reported sleep quality
and BMI z-scores, but not sleep duration measured by actigraphy
(68). Sleep quality was measured using participant or parent
questionnaires (Adolescent Sleep Hygiene Scale, Pittsburgh
Sleepiness Scale, Sleep Disturbance Scale for Children, and
Pediatric Daytime Sleepiness Scale). BMI z-scores decreased
significantly from a baseline mean of 0.79 (SD 1.18) to a post-
intervention mean of 0.66 (SD 1.19). While preliminary studies
are showing potential, well-designed randomized controlled
trials to assess if sleep interventions ultimately improve obesity
and cardiometabolic health in youth are warranted.
CONCLUSION
Poor sleep and obesity are concurrent epidemics in youth.
Insufficient sleep duration and poorer sleep quality are associated
with a greater BMI and markers of cardiometabolic risk,
including insulin resistance, dyslipidemia, and higher blood
pressure in youth. Obese youth are more likely to have OSA
linked with cardiometabolic risk, but a clear association between
OSA and type 2 diabetes in youth has not been established.
Whether sleep interventions can improve pediatric obesity and
cardiometabolic health in youth is yet to be determined.
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